Demographics (2)
- AGE - Age (phv00174311.v1.p1)
- GENDER - Gender (phv00174312.v1.p1)
Disease Events (15)
- ASC_A - Ascites (phv00174317.v1.p1)
- BPER_A - Spontaneous bacteria peritonitis (phv00174318.v1.p1)
- ENCE_A - Encephalopathy (phv00174319.v1.p1)
- ESOPH_VAR - Esophogeal varices baseline (phv00174322.v1.p1)
- esoph_var_M24 - Esophogeal varices M24 (phv00174323.v1.p1)
- esoph_var_M48 - Esophogeal varices M48 (phv00174324.v1.p1)
- HCC_PHCC_A - HCC developed (phv00174307.v1.p1)
- HCVRNAP_W20 - HCV RNA negative end of W20 (phv00174305.v1.p1)
- HCVRNAP_W48 - HCV RNA negative end of W48 (phv00174306.v1.p1)
- LIVER_REL - Death Liver related (phv00174314.v1.p1)
- liverdeath_trans - Liver deaths or transplant (phv00174333.v1.p1)
- portgast_BL - Portal gastropathy baseline (phv00174326.v1.p1)
- portgast_M24 - Portal gastropathy M24 (phv00174327.v1.p1)
- portgast_M48 - Portal gastropathy M48 (phv00174328.v1.p1)
- SVR - Patient type: SVR (negative wk72) (phv00174335.v1.p1)
General Health (1)
- TRANS_A - Liver transplant (phv00174320.v1.p1)
Race and Ethnicity (1)
- RACE4 - Race/ethnicity (phv00174313.v1.p1)
Other (28)
- ANALYTE_TYPE - Analyte type (phv00174341.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00174340.v1.p1)
- breakthrough - Patient type: breakthrough (phv00174336.v1.p1)
- consent - Consent group (phv00174300.v1.p1)
- CTP_A - CTP >=7 (phv00174316.v1.p1)
- DTH_A - Death all cause (phv00174315.v1.p1)
- fibro_ishak_M24 - Ishak Fibrosis score at visit M24 (phv00174309.v1.p1)
- fibro_ishak_M48 - Ishak Fibrosis score at visit M48 (phv00174310.v1.p1)
- fibro_ishak_s00 - Ishak Fibrosis score at visit S00 (phv00174308.v1.p1)
- HAI_IMP2_M24 - HAI improved by 2+ S00 to M24 (phv00174330.v1.p1)
- HAI_IMP2_M48 - HAI improved by 2+ S00 to M48 (phv00174331.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00174343.v1.p1)
- IS_TUMOR - Tumor status (phv00174342.v1.p1)
- LOGDROP2 - Early virological response (EVR)>= 2 log decrease in HCV RNA by week 12 (phv00174304.v1.p1)
- pgastprogr61 - Worsening of baseline PHG (phv00174329.v1.p1)
- randomized - Patient randomized into HALT-C trial (phv00174338.v1.p1)
- relapse - Patient type: relapse (phv00174337.v1.p1)
- RVR - TMA results non-reactive at wk 4 (phv00174332.v1.p1)
- samp_source - Sample source (phv00180636.v1.p1)
- sampid - Sample ID (phv00174302.v1.p1)
- sampid - De-identified sample ID (phv00174339.v1.p1)
- SAMPLE_USE - Sample Use (phv00174303.v1.p1)
- source_sampid - Sample source ID (phv00180635.v1.p1)
- subjid - Subject ID (phv00174334.v1.p1)
- subjid - Subject ID (phv00174301.v1.p1)
- subjid - Subject ID (phv00174299.v1.p1)
- TPI - Two point increase in Ishak Fibrosis score (phv00174321.v1.p1)
- vprogr - Worsening of baseline varices (phv00174325.v1.p1)